Recent Finacing
Recent Raise
Noscendo develops an NGS-based IVD platform and algorithms that analyze cell-free DNA to detect and prioritize over 1,500 bloodstream pathogens, supporting mail-in and on-site hospital diagnostics.
Focus Areas
Recent Investors
Funding rounds
Investors
